Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
28 July, 2017 08:22 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
SSPDL inks JDA for development of premium residential apartments in Chennai - 27-Jul-2017 11:19
Tata Motors expands range of commercial vehicles in Philippines - 27-Jul-2017 10:22
VA Tech Wabag bags STP order worth Rs 3.86 bn - 27-Jul-2017 10:13
HCL Technologies quarterly profit up 8% - 27-Jul-2017 09:09
Maruti Suzuki launches first NEXA Service workshop at Gurugram - 27-Jul-2017 08:50
Yes Bank Q1 earnings jump 31.9% to Rs 9.65 bn - 26-Jul-2017 16:11
MBL Infra selects Welspun Ent as sponsorer for two projects - 26-Jul-2017 13:43
Hero Motocorp quarterly net rises 4% - 26-Jul-2017 10:57
TD Power Systems bags order for supply of traction motor components - 26-Jul-2017 10:24
Cipla in partnership with MMV launches quality-assured RAS - 26-Jul-2017 10:19
Suzlon wins 50.40 MW overseas wind power project - 26-Jul-2017 09:50
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer